Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge

Autor:	Ruchika Jain, Theresa Madaline, Chitra Punjabi Katiyar, Kelsie Cowman, Wendy Szymczak, Gregory Weston, Rachel Bartash, Priya Nori, Philip Gialanella, Victor Chen, Inessa Gendlina, Yi Guo, Marilou Corpuz, Margaret Aldrich
Rok vydání:	2020
Předmět:	Male Microbiological Techniques Microbiology (medical) 2019-20 coronavirus outbreak medicine.medical_specialty Coronavirus disease 2019 (COVID-19) Epidemiology medicine.drug_class Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Antibiotics New York Bacteremia Drug resistance Severity of Illness Index 03 medical and health sciences 0302 clinical medicine Internal medicine Drug Resistance Bacterial Pandemic Severity of illness Central Venous Catheters Humans Medicine 030212 general & internal medicine 0303 health sciences Coinfection SARS-CoV-2 030306 microbiology business.industry Concise Communication COVID-19 Middle Aged medicine.disease Respiration Artificial Anti-Bacterial Agents Outcome and Process Assessment Health Care Infectious Diseases Mycoses Female business
Zdroj:	Infection Control & Hospital Epidemiology Infection Control and Hospital Epidemiology
ISSN:	1559-6834 0899-823X
DOI:	10.1017/ice.2020.368
Popis:	We observed bacterial or fungal coinfections in COVID-19 patients admitted between March 1 and April 18, 2020 (152 of 4,267, 3.6%). Among these patients, mortality was 57%; 74% were intubated; 51% with bacteremia had central venous catheters. Time to culture positivity was 6–7 days, and 79% had received prior antibiotics. Metallo-β-lactamase–producing E. cloacae coinfections occurred in 5 patients.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dcf27254a700739daad88175248cc9e https://doi.org/10.1017/ice.2020.368 Zobrazit plný text záznamu